Cargando…
Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1
In early breast cancer axillary nodes are usually impalpable and over 50% of such patients may have an axillary clearance when no nodes are involved. This work identifies axillary node status by imaging with a Tc-99m radiolabelled anti-Polymorphic Epithelial Mucin, humanised monoclonal antibody (hum...
Autores principales: | Al-Yasi, A R, Carroll, M J, Ellison, D, Granowska, M, Mather, S J, Wells, C A, Carpenter, R, Britton, K E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364153/ https://www.ncbi.nlm.nih.gov/pubmed/11953817 http://dx.doi.org/10.1038/sj.bjc.6600200 |
Ejemplares similares
-
99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.
por: Biassoni, L., et al.
Publicado: (1998) -
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1
por: Pericleous, L M, et al.
Publicado: (2005) -
The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
por: Berry, N., et al.
Publicado: (1985) -
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer
por: Royer, B, et al.
Publicado: (2010) -
A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.
por: Dhokia, B., et al.
Publicado: (1986)